Shunthi Hingvadi tablet in Menstrual cramps

Phase 2

• Conditions: Health Condition 1: N946- Dysmenorrhea, unspecified

• Registration Number: CTRI/2024/03/064320
• Lead Sponsor: CCRAS

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 April 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. 30 patient with clinical feature of primary dysmenorrhea will be selected.

2.Female patient between 15 to 30 age will be selected.

Exclusion Criteria

1.Female patient with any pelvic Pathology.

2.Patient with history of any other systemic illness.

3.Patient with menstrual irregularities.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in dependency on analgesics <br/ ><br>Reduction in duration of pain <br/ ><br>Reduction in nature of painTimepoint: First Month <br/ ><br>Collection and standardization of drugs <br/ ><br>Manufacture of tablets <br/ ><br>Registration of patient in OPD of Prasuti tantra and streerog Department <br/ ><br> <br/ ><br>Second Month <br/ ><br>Follow Up <br/ ><br> <br/ ><br>Third Month <br/ ><br>Follow Up <br/ ><br> <br/ ><br> <br/ ><br>Third Month <br/ ><br>Follow Up <br/ ><br> <br/ ><br>Fourth Month <br/ ><br>Final Report

Secondary Outcome Measures

Name	Time	Method
Reduction in ConstipationTimepoint: During each Follow Up